• Clarithromycin (SKU A4322): Precision CYP3A Inhibitor for Dr

  2026-07-29

  This article presents scenario-driven guidance for biomedical researchers investigating CYP3A-mediated drug-drug interactions using Clarithromycin (SKU A4322). It highlights evidence-based protocol design, data interpretation, and product reliability with direct links to validated resources for reproducible pharmacokinetic and statin metabolism studies.

• Epalrestat in Translational Neuroprotection: From Diabetic P

  2026-07-29

  Discover how Epalrestat, a potent aldose reductase inhibitor, is advancing neuroprotection research beyond diabetic complications by targeting the KEAP1/Nrf2 pathway. This in-depth analysis uniquely bridges molecular mechanism with translational assay design for Parkinson's disease models.

• Super-Enhancer Regulation of KLF6 Directs hADSC Adipogenesis

  2026-07-28

  Nguyen et al. reveal that super-enhancer-driven KLF6 expression is indispensable for adipogenic differentiation of human adipose-derived stem cells (hADSCs). Their integrative approach uncovers a transcriptional and epigenetic regulatory cascade, with practical implications for dissecting transcription regulation in stem cell and metabolic research.

• Q-VD(OMe)-OPh: Precision Caspase Inhibition for Advanced Apo

  2026-07-28

  Q-VD(OMe)-OPh sets a new benchmark for apoptosis research with its potent, broad-spectrum caspase inhibition and minimal cytotoxicity. Leveraged across cancer and neuroprotection workflows, it enables robust, reproducible results where traditional inhibitors fall short.

• 4-Hydroxytamoxifen: Technical Guide for DMSO-Based Research

  2026-07-27

  4-Hydroxytamoxifen (SKU B6167) is a potent estrogen receptor modulator designed for DMSO-based assays in breast cancer, prostate cancer, and cardiac myocyte research. It is not suitable for protocols requiring aqueous or ethanol solubility, and strict handling and storage are essential to maintain reproducibility.

• 2-Hydroxypropyl-β-cyclodextrin: Practical Solubility Guidanc

  2026-07-27

  2-Hydroxypropyl-β-cyclodextrin addresses the persistent challenge of solubilizing poorly water-soluble, hydrophobic compounds—especially those with aromatic or phenyl groups—by enabling inclusion complex formation. Its validated use is as a solubility enhancer and drug formulation excipient in pharmaceutical and biochemical workflows; applications outside of solubility enhancement are not currently supported by available product documentation.

• Carbenoxolone Disodium: Technical Guide for 11β-HSD Inhibiti

  2026-07-26

  Carbenoxolone disodium is a high-purity 11β-hydroxysteroid dehydrogenase inhibitor suitable for dissecting glucocorticoid regulation, corticosterone metabolism, and gap junction communication in tissue- and cell-based research. It is not recommended for in vivo efficacy studies or workflows needing stringent off-target effect control.

• SW033291: 15-PGDH Inhibitor Workflows for Muscle Repair

  2026-07-25

  SW033291 empowers tissue regeneration research by precisely elevating prostaglandin E2 and enhancing muscle repair, even during GLP-1 RA–induced weight loss. This guide translates recent breakthroughs into actionable protocols and troubleshooting strategies, streamlining advanced workflows for hematopoietic and muscle regeneration studies.

• Golgi-Tracker Green: Decoding Live-Cell Golgi Dynamics in Di

  2026-07-24

  Explore how Golgi-Tracker Green, a BODIPY FL-labeled C5-ceramide probe, uniquely enables high-fidelity, live-cell Golgi apparatus labeling for advanced disease modeling and lipid pathway studies. This article reveals novel applications, protocol insights, and the clinical relevance of Golgi imaging in current oncology research.

• 5X Protein Loading Buffer (Reducing): Practical SDS-PAGE Gui

  2026-07-24

  5X Protein Loading Buffer (Reducing) is optimized for protein sample preparation in SDS-PAGE workflows that require consistent denaturation and disulfide bond reduction. It should only be applied in assays focused on protein molecular weight separation under reducing conditions and is not appropriate for maintaining native or non-reducing protein structures.

• CBD Modulates Orofacial Pain via CB1/CB2 and Serotonin Pathw

  2026-07-23

  This study demonstrates that cannabidiol (CBD) robustly alleviates both sensory and affective dimensions of orofacial inflammatory pain in mouse models. By dissecting peripheral and central endocannabinoid mechanisms, the research highlights CBD’s translational potential for multidimensional pain management and the importance of cannabinoid receptor signaling in neuropharmacology.

• Epalrestat Activates KEAP1/Nrf2 for Neuroprotection in PD Mo

  2026-07-23

  Jia et al. (2025) provide compelling evidence that Epalrestat, a clinically used aldose reductase inhibitor, directly binds KEAP1 and activates the Nrf2 pathway, offering neuroprotection in Parkinson’s disease models. This mechanistic insight supports the repurposing of Epalrestat beyond diabetic neuropathy, with implications for oxidative stress research and neurodegeneration.

• Dual Luciferase Reporter Gene System: Precision in Oncogenic

  2026-07-22

  Explore how the Dual Luciferase Reporter Gene System enables unparalleled precision in gene expression regulation research. This article spotlights its distinct advantages for dissecting oncogenic pathways, leveraging recent breakthroughs and advanced assay strategies.

• Niclosamide in Cancer Models: Assay Design and STAT3 Targeti

  2026-07-22

  Explore how Niclosamide, a potent STAT3 signaling pathway inhibitor, enables advanced assay design and mechanistic insights for cancer research. This article uniquely bridges in vivo models, assay optimization, and translational perspectives for oncology studies.

• WEHI-539: Advanced Strategies for BCL-XL Inhibition in Cance

  2026-07-21

  Explore how WEHI-539, a potent BCL-XL inhibitor, enables precise apoptosis induction and reveals new strategies for overcoming therapeutic resistance in cancer stem cells. This article uniquely integrates mechanistic insights and protocol optimization, spotlighting recent breakthroughs in glioblastoma research.

16352 records 1/1091 page Next 12345 下5页 Last page